Evaluation of Non-response to Hepatitis B Vaccines in Individuals Over 15 Years in the Centre Region of Cameroon: A Cross-sectional Study

J. Essindi, Jacky Njiki Bikoï, Carol Sake, D. S. Mbaga, Arnaud Franck Elang, C. Mikangue, Aicha Ngoutane, Alexandra Emmanuelle Membangbi, Sabine Aimée Touangnou-Chamda, S. R. Essama
{"title":"Evaluation of Non-response to Hepatitis B Vaccines in Individuals Over 15 Years in the Centre Region of Cameroon: A Cross-sectional Study","authors":"J. Essindi, Jacky Njiki Bikoï, Carol Sake, D. S. Mbaga, Arnaud Franck Elang, C. Mikangue, Aicha Ngoutane, Alexandra Emmanuelle Membangbi, Sabine Aimée Touangnou-Chamda, S. R. Essama","doi":"10.9734/mrji/2024/v34i11424","DOIUrl":null,"url":null,"abstract":"Background: To investigate the risks factors associated to the non-response of hepatitis B (HB) immunization in participants over the age of 15 years. \nMethods: From October 2020 to December 2021, data were collected from individuals aged over 15 years who receive at least one dose of vaccine. An algorithm consisted of three (03) tests researching anti-HBs whose detectability threshold was 10 IU/L and anti-HBc. \nResults: A total of 330 participants were included in this study, among which 158 received three doses of vaccine, of these 83.59% and 6,6% were found positive respectively to anti HBs and anti-HBc. We noted that, age [30 – 40] years [OR= 2.41; CI at 95% (1.24 – 4.80)]; single status [OR=10.80; CI at 95% (1.78 – 114.8)], obesity [OR=2.99; CI at 95% (1.13 – 7.27)], alcohol [OR=10.80; CI at 95% (1.78 – 114.8)]; HEPATITIS vaccine [OR=3.40; CI at 95% (1.24 – 9.10)] were associated with non-response to hepatitis B vaccines. \nConclusion: Non-response to hepatitis B vaccination has been influenced by several risk factors that should be considered during the vaccination process.","PeriodicalId":18450,"journal":{"name":"Microbiology Research Journal International","volume":"19 16","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbiology Research Journal International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/mrji/2024/v34i11424","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To investigate the risks factors associated to the non-response of hepatitis B (HB) immunization in participants over the age of 15 years. Methods: From October 2020 to December 2021, data were collected from individuals aged over 15 years who receive at least one dose of vaccine. An algorithm consisted of three (03) tests researching anti-HBs whose detectability threshold was 10 IU/L and anti-HBc. Results: A total of 330 participants were included in this study, among which 158 received three doses of vaccine, of these 83.59% and 6,6% were found positive respectively to anti HBs and anti-HBc. We noted that, age [30 – 40] years [OR= 2.41; CI at 95% (1.24 – 4.80)]; single status [OR=10.80; CI at 95% (1.78 – 114.8)], obesity [OR=2.99; CI at 95% (1.13 – 7.27)], alcohol [OR=10.80; CI at 95% (1.78 – 114.8)]; HEPATITIS vaccine [OR=3.40; CI at 95% (1.24 – 9.10)] were associated with non-response to hepatitis B vaccines. Conclusion: Non-response to hepatitis B vaccination has been influenced by several risk factors that should be considered during the vaccination process.
喀麦隆中部地区 15 岁以上人群对乙型肝炎疫苗无反应的评估:横断面研究
背景:调查与 15 岁以上参与者不响应乙型肝炎(HB)免疫接种相关的风险因素。方法:从 2020 年 10 月至 2021 年 12 月,收集 15 岁以上参与者的数据:从 2020 年 10 月至 2021 年 12 月,从至少接种过一剂疫苗的 15 岁以上人群中收集数据。算法包括三(03)项检测,研究可检测阈值为 10 IU/L 的抗-HBs 和抗-HBc。结果共有 330 人参与了这项研究,其中 158 人接种了三剂疫苗,其中 83.59% 和 6.6% 的人分别发现抗 HBs 和抗 HBc 阳性。我们注意到,年龄[30 - 40] 岁[OR= 2.41;CI 为 95% (1.24 - 4.80)];单身[OR=10.80;CI 为 95% (1.78 - 114.8)];肥胖[OR=2.99;CI 为 95% (1.13 - 7.27)];酗酒[OR=2.41;CI 为 95% (1.24 - 4.80)]。27)]、酒精[OR=10.80;CI 为 95% (1.78 - 114.8)]、HEPATITIS 疫苗[OR=3.40;CI 为 95% (1.24 - 9.10)]与乙肝疫苗无反应相关。结论乙型肝炎疫苗接种无反应受多种风险因素的影响,在疫苗接种过程中应考虑这些因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信